OnTracka closes consumer app to focus on clinical trials by Adam Sheldon August 11, 2026August 11, 2026 Australian digital health firm OnTracka has shut its consumer app to focus exclusively on providing infrastructure […]
News in brief: Judgment reserved in CDA Clinics QLD legal case; Nexalis completes Phase 1 IRX-616a dosing by Adam Sheldon May 18, 2026June 8, 2026
News in brief: Nexalis advances IRX-616a and IRX-211 programs; Vitura heralds Doctors on Demand growth; Elixinol improves cash flow by Adam Sheldon April 20, 2026June 11, 2026
News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial by Adam Sheldon March 17, 2026June 8, 2026
News in brief: Avecho gains key patent allowances; Montu expands medical affairs team by Adam Sheldon December 9, 2025February 21, 2026
Failed clinical trial highlights perils of medicinal cannabis research by Adam Sheldon September 30, 2025October 1, 2025
Family experience of MC drives Medibis to fund autism anxiety trial by Adam Sheldon August 5, 2025August 19, 2025
From tracking app to industry ally: OnTracka’s critical role in shifting the cannabis needle by Steve Jones May 13, 2025May 15, 2025
Manufacturer and supplier iX Biopharma insists finances are secure despite auditor concerns by Steve Jones October 9, 2024October 10, 2024
Number of clinical trials using cannabis ‘exploded’ in last decade by Martin Lane September 1, 2023April 30, 2024
